Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dydrogesterone for Threatened Abortion
NCT04788108Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Aug 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dydrogesterone in threatened abortion, sponsored by Chulalongkorn University. Started Aug 2021; status: completed.
02
Drugs
dydrogesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on NCT04788108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788108.